Skip to search formSkip to main content

CP 135807

Known as: CP 135,807, CP-135,807, CP-135807 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
The terminal 5-HT1B autoreceptors have attracted great pharmacological interest since they are potential targets for compounds… Expand
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
Is this relevant?
2002
2002
Abstract. The possibility that 5-HT1B receptors display constitutive activity in vivo, i.e. have a basal agonist-independent… Expand
  • table 1
  • table 2
Is this relevant?
2001
2001
Abstract. Objectives: The present study was undertaken to characterize the regulation of serotonin (5-HT) efflux and neuronal… Expand
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
Is this relevant?
1999
1999
We have previously shown that the antipsychotic drug risperidone enhances serotonin (5-HT) output in the rat frontal cortex (FC… Expand
Is this relevant?
1997
1997
GR127935 is a selective antagonist of release-modulating 5-HT1B/1D autoreceptors on serotonergic terminals and, as such, would be… Expand
Is this relevant?
1996
1996
In vivo microdialysis in guinea pig hypothalamus was used to study the effect of serotonin [5-hydroxytryptamine (5-HT)] subtype… Expand
Is this relevant?
1996
1996
Abstract CP-135,807 [3-(N-methylpyrrolidin-2R-ylmeth- yl)-5-(3-nitropyrid-2-yl)amino-1H-indole] binds with high affinity to… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?